Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals

Central venous access devices (CVADs) facilitate repeated or urgent treatments for paediatric haemophilia patients, but are associated with complications. This study examined the burden of illness, healthcare utilization and costs for CVADs in a real‐world hospital setting.

[1]  Flora Peyvandi,et al.  The past and future of haemophilia: diagnosis, treatments, and its complications , 2016, The Lancet.

[2]  B. Glader,et al.  Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  P. Fogarty,et al.  Gene therapy for hemophilia: past, present and future. , 2016, Seminars in hematology.

[4]  A. Ullman,et al.  Complications of Central Venous Access Devices: A Systematic Review , 2015, Pediatrics.

[5]  P. Lähteenmäki,et al.  Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  L. Valentino,et al.  Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study , 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  Richard M. Heiberger,et al.  Data and Statistics , 2015 .

[8]  M. Morfini,et al.  Current and evolving features in the clinical management of haemophilia. , 2014, Blood transfusion = Trasfusione del sangue.

[9]  J. Crameri,et al.  Central venous access device‐related infections in patients with haemophilia , 2013, Journal of paediatrics and child health.

[10]  S. Saint,et al.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. , 2013, The Cochrane database of systematic reviews.

[11]  M. Franchini,et al.  Past, present and future of hemophilia: a narrative review , 2012, Orphanet Journal of Rare Diseases.

[12]  C. Kessler,et al.  Health care expenditures for Medicaid‐covered males with haemophilia in the United States, 2008 , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  C. Kessler,et al.  Healthcare expenditures for males with haemophilia and employer‐sponsored insurance in the United States, 2008 , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[14]  C. Hay,et al.  The principal results of the International Immune Tolerance Study: a randomized dose comparison. , 2012, Blood.

[15]  A. Coppola,et al.  Treatment of hemophilia: a review of current advances and ongoing issues , 2010, Journal of blood medicine.

[16]  C. Rey,et al.  Mechanical complications during central venous cannulations in pediatric patients , 2009, Intensive Care Medicine.

[17]  E. Santagostino,et al.  Improved treatment feasibility in children with hemophilia using arteriovenous fistulae: the results after seven years of follow-up , 2009, Haematologica.

[18]  V. Blanchette,et al.  Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  L. Valentino,et al.  Central venous access devices in patients with hemophilia , 2005, Expert review of medical devices.

[20]  L. Valentino,et al.  Consensus recommendations for use of central venous access devices in haemophilia , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  A. Daneman,et al.  A prospective, longitudinal study of central venous catheter‐related deep venous thrombosis in boys with hemophilia , 2004, Journal of thrombosis and haemostasis : JTH.

[22]  L. Valentino,et al.  Central venous access devices in haemophilia , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  D. Globe,et al.  Utilization of care in haemophilia: a resource‐based method for cost analysis from the Haemophilia Utilization Group Study (HUGS) , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[24]  L. Peddle,et al.  Surveillance of infectious complications associated with central venous access devices in children with haemophilia , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  R. Janco,et al.  Complications of central venous access devices in paediatric haemophilia patients , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[26]  K. Kurnik,et al.  Catheter-related thrombosis in children with hemophilia A: evidence of a multifactorial disease. , 2002, Blood.

[27]  P. Miller.  Central venous access devices , 2006, Bone Marrow Transplantation.

[28]  C. Quinn,et al.  Catheter-related deep venous thrombosis in children with hemophilia. , 2001, Blood.

[29]  B. Evatt,et al.  Occurrence of hemophilia in the United States , 1998 .

[30]  B. Evatt,et al.  Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators. , 1998, American journal of hematology.